RVMD – Revolution Medicines, Inc.
Revolution Medicines, Inc.RVMD
$143.33Name : Revolution Medicines, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $28,403,200,000.00
EPSttm : -5.95
Revolution Medicines, Inc.
$143.33
5.15%$7.02
RVMD — Price & Forward EBITDA
Forward EBITDA (M)
Float Short %
8.95
Margin Of Safety %
Put/Call OI Ratio
1.63
EPS Next Q Diff
-0.03
EPS Last/This Y
-1.66
EPS This/Next Y
0.87
Price
136.31
Target Price
150.16
Analyst Recom
1
Performance Q
14.89
Upside
-252.0%
Beta
1.12
Ticker: RVMD
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-03-17 | RVMD | 99.05 | 0.91 | 0.04 | 133047 |
| 2026-03-18 | RVMD | 98.07 | 0.81 | 0.90 | 142010 |
| 2026-03-19 | RVMD | 99.24 | 0.86 | 0.52 | 142243 |
| 2026-03-20 | RVMD | 95.77 | 0.86 | 4.77 | 142583 |
| 2026-03-23 | RVMD | 96.53 | 1.80 | 0.39 | 111130 |
| 2026-03-24 | RVMD | 95.16 | 1.78 | 2.23 | 113852 |
| 2026-03-25 | RVMD | 94.28 | 1.78 | 3.90 | 114096 |
| 2026-03-26 | RVMD | 93.57 | 1.70 | 1.04 | 112544 |
| 2026-03-27 | RVMD | 92.55 | 1.69 | 5.58 | 113024 |
| 2026-03-30 | RVMD | 92.67 | 1.69 | 39.32 | 113309 |
| 2026-03-31 | RVMD | 97.18 | 1.77 | 1.83 | 117192 |
| 2026-04-01 | RVMD | 98.65 | 1.72 | 4.14 | 115532 |
| 2026-04-02 | RVMD | 99.13 | 1.63 | 6.57 | 114087 |
| 2026-04-06 | RVMD | 95.42 | 1.64 | 3.14 | 115218 |
| 2026-04-08 | RVMD | 96.77 | 1.64 | 0.46 | 117286 |
| 2026-04-09 | RVMD | 96.16 | 1.62 | 1.16 | 118278 |
| 2026-04-13 | RVMD | 134.55 | 1.63 | 1.60 | 129729 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-03-17 | RVMD | 99.05 | -58.7 | -196.5 | -7.60 |
| 2026-03-18 | RVMD | 98.05 | -58.7 | -572.3 | -7.60 |
| 2026-03-19 | RVMD | 99.27 | -58.7 | -595.5 | -7.60 |
| 2026-03-20 | RVMD | 95.78 | -58.7 | -529.4 | -7.60 |
| 2026-03-23 | RVMD | 96.60 | -58.7 | -544.9 | -7.60 |
| 2026-03-24 | RVMD | 95.53 | -58.8 | -524.6 | -7.61 |
| 2026-03-25 | RVMD | 94.28 | -58.8 | -500.9 | -7.61 |
| 2026-03-26 | RVMD | 93.30 | -58.8 | -482.4 | -7.61 |
| 2026-03-27 | RVMD | 92.47 | -58.8 | -466.7 | -7.61 |
| 2026-03-30 | RVMD | 92.71 | -58.8 | -471.2 | -7.61 |
| 2026-03-31 | RVMD | 97.16 | -58.8 | -555.5 | -7.61 |
| 2026-04-01 | RVMD | 98.64 | -58.8 | -583.6 | -7.61 |
| 2026-04-02 | RVMD | 99.20 | -58.8 | -594.1 | -7.61 |
| 2026-04-06 | RVMD | 95.40 | -58.8 | -522.1 | -7.61 |
| 2026-04-07 | RVMD | 96.27 | -58.8 | -609.7 | -7.61 |
| 2026-04-09 | RVMD | 96.22 | -58.8 | -537.7 | -7.61 |
| 2026-04-10 | RVMD | 96.43 | -58.8 | -541.6 | -7.61 |
| 2026-04-13 | RVMD | 136.31 | -58.8 | -1297.3 | -7.61 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-03-17 | RVMD | -1.43 | 2.60 | 8.19 |
| 2026-03-18 | RVMD | -1.43 | 2.60 | 8.19 |
| 2026-03-19 | RVMD | -1.31 | 2.60 | 8.19 |
| 2026-03-20 | RVMD | -1.43 | 2.60 | 8.19 |
| 2026-03-23 | RVMD | -1.43 | 2.60 | 8.19 |
| 2026-03-24 | RVMD | -1.43 | 2.60 | 8.19 |
| 2026-03-25 | RVMD | -1.43 | 2.60 | 8.39 |
| 2026-03-26 | RVMD | -1.43 | 2.60 | 8.39 |
| 2026-03-27 | RVMD | -1.57 | 2.60 | 8.39 |
| 2026-03-30 | RVMD | -1.57 | 2.60 | 8.39 |
| 2026-03-31 | RVMD | -1.57 | 2.60 | 8.39 |
| 2026-04-01 | RVMD | -1.57 | 2.60 | 8.39 |
| 2026-04-02 | RVMD | -1.57 | 2.60 | 8.39 |
| 2026-04-06 | RVMD | -1.57 | 2.61 | 8.39 |
| 2026-04-07 | RVMD | -1.57 | 2.61 | 8.39 |
| 2026-04-08 | RVMD | -1.57 | 2.61 | 8.39 |
| 2026-04-09 | RVMD | -1.57 | 2.61 | 8.39 |
| 2026-04-10 | RVMD | -1.57 | 2.61 | 8.39 |
| 2026-04-13 | RVMD | -1.57 | 2.67 | 8.95 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-1.86
Avg. EPS Est. Current Quarter
-1.79
Avg. EPS Est. Next Quarter
-1.89
Insider Transactions
-1.57
Institutional Transactions
2.67
Beta
1.12
Average Sales Estimate Current Quarter
3
Average Sales Estimate Next Quarter
18
Fair Value
Quality Score
12
Growth Score
22
Sentiment Score
52
Actual DrawDown %
-9.5
Max Drawdown 5-Year %
-66.1
Target Price
150.16
P/E
Forward P/E
PEG
P/S
P/B
16.46
P/Free Cash Flow
EPS
-5.92
Average EPS Est. Cur. Y
-7.61
EPS Next Y. (Est.)
-6.74
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
Relative Volume
5.8
Return on Equity vs Sector %
-96.7
Return on Equity vs Industry %
-80.1
EPS 1 7Days Diff
EPS 1 30Days Diff
-0.01
EBIT Estimation
-1297.3
◆
RVMD
Healthcare
$136.30
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
84
Range 1M
96.6%
Sup Dist
30.3%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
-31%
EPS NY
18.5%
52W%
98.5%
Long-Term Value
Quality companies, undervalued
WEAK
🟡 HOLD
+10.2% upside
Upside
+10.2%
Quality
12
Revolution Medicines, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 883
Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline consist of RAS(ON) inhibitors that binds RAS variants to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors to suppress cooperating targets and pathways that sustain RAS-addicted cancers. Its RAS(ON) inhibitors include daraxonrasib (RMC-6236), elironrasib G12C (RMC-6291) which is in early clinical development for the treatment of solid tumors, and zoldonrasib G12D (RMC-9805), which are in phase 3 registrational trial evaluating the combination of daraxonrasib with zoldonrasib in patients with 1L PDAC; and development candidates comprise RMC-5127 (G12V) which is in clinical trial, RMC-0708 (Q61H), that is in clinical trial; and RMC-8839 (G13C). Revolution Medicines, Inc. was incorporated in 2014 and is headquartered in Redwood City, California.
RVMD
Latest News
—
Caricamento notizie per RVMD…
stock quote shares RVMD – Revolution Medicines, Inc. Stock Price stock today
news today RVMD – Revolution Medicines, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch RVMD – Revolution Medicines, Inc. yahoo finance google finance
stock history RVMD – Revolution Medicines, Inc. invest stock market
stock prices RVMD premarket after hours
ticker RVMD fair value insiders trading